Joy is a medical statistician in Queen Mary University of London, United Kingdom, with keen interests in personalised healthcare and improving health inequality. She has 5+ years of experience in innovating the use of screening diagnostics to improve bowel cancer prevention and screening programmes in the UK. She also works with NHS Breast Screening and local hospital trust in East London to improve Breast Screening Pathways to improve access and reduce inequality.

Dr. Yingye Zheng is a professor in the Department of Biostatistics at Fred Hutchinson Cancer Center. Her research interests include the statistical evaluation of biomarker-based tests for cancer screening. She has extensive collaborative experience leading coordinating centers for researching the utility of novel cancer screening modalities and the quality of cancer screening delivery in the community.

Anne Mette Kaag Kristensen is a Research Assistant at Research Unit for Screening and Epidemiology at Clinical Biochemistry, Lillebaelt Hospital with a background in computational biomedicine. Her work focuses on the evaluation of the Danish Colorectal Cancer Screening Programme, where she applies advanced analytical methods to assess and improve screening effectiveness

Dr. Tickle is a postdoctoral scientist in the Cancer Surveillance Branch at the International Agency for Research on Cancer. Her research focuses on modelling the combined effects of smoking and alcohol control policies on future cancer incidence and mortality in the Nordic countries. Previously, she completed her PhD with Professor Peter Sasieni, where she explored indicators and metrics for monitoring progress in early cancer diagnosis. This work employed a range of quantitative and qualitative methods, utilising aggregate and individual-level registry data. Notably, she investigated the impact of the Danish Breast Screening Programme analysing data from over one million women.

Amanda Dibden is a statistician at the Wolfson Institute of Population Health, Queen Mary University of London. Since completing her MSc in Medical Statistics at the London School of Hygiene and Tropical Medicine, Amanda’s research has focused on evaluating the benefits and harms of breast cancer screening in the UK. In 2024, Amanda successfully completed her PhD with her thesis entitled “Evaluating the long-term effects of the UK breast cancer screening programme”.

Emily is a Statistician and PhD student at the Wolfson Institute of Population Health at Queen Mary University of London. As a Statistician she works primarily on ovarian and prostate cancer screening trials and has developed an interest in using statistical methods to improve the efficiency of clinical trials. Her PhD research, funded by the MRC-NIHR Trials Methodology Research Partnership, is focused on developing statistical methods to evaluate surrogate endpoints in cancer screening trials. Emily completed a BSc in Statistics at UCL and an MSc in Health Data Science at the London School of Hygiene and Tropical Medicine.